Updated:
J&A Partners
Ramesh Juneja directs his Mankind Pharma wealth into J&A Partners, a Scottsdale family office targeting Asian healthtech, proptech, and climate deals.
J&A Partners
Ramesh Juneja founded J&A Partners as the single-family investment vehicle for the wealth generated through Mankind Pharma, the Indian drugmaker he built into one of the country's largest by prescription base. The Scottsdale-headquartered office is guided by principals Rajeev Juneja and Arjun Juneja, both senior Mankind Pharma operators, cementing the link between the family's operating business and its investment platform. The firm extends beyond the pharmaceutical brand by committing to direct stakes in early-stage and late-stage companies. Its focus areas include Digital Health, Healthcare Services, PropTech, and FinTech, with a geographic footprint concentrated on the Asian market. J&A Partners structures its commitments through direct co-investments and special-purpose vehicles, often alongside frequent partner Dinesh Mody Ventures. Confirmed technology lenses include AI/ML and Edge & IoT applications within its sector verticals. The principals participate in the Young Presidents' Organization network, which can serve as a deal-discovery channel among peer operators and high-net-worth families. The family's philanthropic activity is housed formally under the Mankind Pharma Foundation, creating a separate legal conduit for charitable capital. No external figure for total deployment or team headcount is publicly available. Structural differentiation lies in the embedded operational DNA: the family office does not outsource sector expertise to external consultants in pharmaceutical-adjacent verticals but instead draws on the executive team of Mankind Pharma — where Rajeev Juneja serves as Vice Chairman and Managing Director and Arjun Juneja as COO — creating a sourcing advantage for drug-delivery, healthtech, and adjacent supply-chain investments.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Scottsdale
Corporate office
Scottsdale, AZ, United States
Principals
Ramesh Juneja
Founder
Rajeev Juneja
Principal
Arjun Juneja
Principal
Sector focus
Frequently asked questions
Who runs investment decisions at J&A Partners?
Founder Ramesh Juneja oversees the family office's strategy, with active participation from Rajeev Juneja and Arjun Juneja, both holding senior operating roles at Mankind Pharma. This dual operating-investing structure means investment decisions draw heavily on sector expertise from the pharmaceutical business, rather than a separated investment committee.
Where does the underlying wealth come from?
The wealth originates from Mankind Pharma, the Indian pharmaceutical company co-founded by Ramesh Juneja that ranks among the country's largest drug manufacturers. The family's promoter stake in the publicly traded company forms the core asset base behind J&A Partners.
Does J&A Partners participate in fund commitments or only direct deals?
The primary posture is direct co-investment and special-purpose vehicles rather than broad fund commitments. J&A Partners co-invests frequently alongside Dinesh Mody Ventures in early-stage and late-stage opportunities, suggesting a preference for specific deal-level exposure over blind-pool structures.
How does J&A Partners source proprietary deal flow?
Deal flow benefits from the principals' operating visibility in the pharmaceutical and broader Indian business community. Membership in the Young Presidents' Organization provides an additional peer network channel, while the office's preference for co-investing with Dinesh Mody Ventures signals a reliance on trusted operational partners for deal origination.
Which sectors does J&A Partners explicitly avoid?
Publicly observable commitments cluster around Digital Health, Healthcare Services, PropTech, FinTech, Supply Chain & Logistics, and ClimateTech. There is no public record of the firm deploying into traditional heavy industry, fossil-fuel infrastructure, or consumer packaged goods outside health and wellness.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: